BRIEF-Valeant appoints Paul Herendeen as chief financial officer

Mon Aug 22, 2016 6:20am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 22 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant pharmaceuticals appoints Paul S. Herendeen as executive vice president, finance and chief financial officer

* Herendeen will take over role of chief financial officer from Robert L. Rosiello effective immediately

* Prior to joining Valeant, Herendeen served as executive vice president and chief financial officer of Zoetis Inc. For two years

* Rosiello will assume responsibility for corporate development and strategy and continues as evp and an executive committee member Source text for Eikon: Further company coverage: